Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 81 Rectal Neoplasms 40 Colonic Neoplasms 34 Pancreatic Neoplasms 27 Stomach Neoplasms 22 Carcinoma, Hepatocellular 21 Breast Neoplasms 21 Esophageal Neoplasms 20 Neoplasm Metastasis 19 Nasopharyngeal Carcinoma 15 Esophageal Squamous Cell Carcinoma 13 Neoplasms 7 Head and Neck Neoplasms 7 Liver Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Carcinoma, Squamous Cell 5 Anus Neoplasms 5 Adenocarcinoma Of Esophagus 5 Nasopharyngeal Neoplasms 4 Inflammatory Breast Neoplasms 4 Cholangiocarcinoma 4 Recurrence 3 Gastrointestinal Neoplasms 3 Gallbladder Neoplasms 3 Digestive System Neoplasms 3 Breast Neoplasms, Male 3 Bile Duct Neoplasms 3 Solid Tumors 2 Ovarian Neoplasms 2 Neutropenia 2

Interventions

irinotecan sucrosofate 1 folfirinox 1 Taxes 1 Surgical Procedures, Operative 1 Radiotherapy 1 Radiosurgery 1 Oxaliplatin 1 Leucovorin 1 Gemcitabine 1 Folfox protocol 1 Fluorouracil 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Adenocarcinoma × Fluorouracil × Clear all

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡